Evidence-Based, Pharmacological Treatment Guideline for Depression in Korea, Revised Edition
Journal of Korean Medical Science
;
: 468-484, 2014.
Artigo
em Inglês
| WPRIM
| ID: wpr-216491
ABSTRACT
This paper aims to introduce, summarize, and emphasize the importance of the 'Evidence-Based, Pharmacological Treatment Guideline for Depression in Korea, Revised Edition'. The guideline broadly covers most aspects of the pharmacological treatment of patients in Korea diagnosed with moderate to severe major depression according to the DSM-IV TR. The guideline establishment process involved determining and answering a number of key questions, searching and selecting publications, evaluating recommendations, preparing guideline drafts, undergoing external expert reviews, and obtaining approval. A guideline adaptation process was conducted for the revised edition. The guideline strongly recommends pharmacological treatment considered appropriate to the current clinical situation in Korea, and should be considered helpful when selecting the appropriate pharmacological treatment of patients diagnosed with major depressive disorder. Therefore, the wide distribution of this guideline is recommended.
Texto completo:
DisponíveL
Índice:
WPRIM (Pacífico Ocidental)
Assunto principal:
Transtornos Psicóticos
/
Antipsicóticos
/
Índice de Gravidade de Doença
/
Efeito Placebo
/
Bases de Dados Factuais
/
Inibidores da Captação de Neurotransmissores
/
Depressão
/
Tolerância a Medicamentos
/
Prática Clínica Baseada em Evidências
/
República da Coreia
Tipo de estudo:
Guia de Prática Clínica
Limite:
Humanos
País/Região como assunto:
Ásia
Idioma:
Inglês
Revista:
Journal of Korean Medical Science
Ano de publicação:
2014
Tipo de documento:
Artigo
Similares
MEDLINE
...
LILACS
LIS